40 participants
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2025-11-19
- Completion:
- 2028-02-28
Conditions
- Huntington's Disease
Interventions
- DRUG
No Results Yet